Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: EMBARK Study Post-Hoc Analysis By Age - Enzalutamide +/- Leuprolide in Patients With High-Risk Biochemically Recurrent Prostate Cancer
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Neal Shore
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Neal Shore
58 views
September 27, 2024
Comments 0
Login to view comments.
Click here to Login